Androgens in focus
Before launching a new product for the treatment of castration-resistant prostate cancer, Astellas wanted to draw the attention of uro-oncologists to the latest scientific findings on the development and treatment of prostate cancer.
In cooperation with leading opinion leaders in urology, we identified the relevant content for a review, which we were able to produce in a very short time due to the high indication expertise of our medical writers.
The manuscript was accepted for publication in the journal “Der Urologe” without any problems. A positive expectation of the new product was raised in the community. This made it easier for Astellas to convincingly explain the significance of the new product in patient care in further pre-launch and launch communication.